Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cataract Extraction | 12 | 2024 | 216 | 3.080 |
Why?
|
| Cataract | 13 | 2024 | 222 | 2.670 |
Why?
|
| Visual Acuity | 15 | 2024 | 824 | 2.310 |
Why?
|
| Lens Implantation, Intraocular | 12 | 2024 | 342 | 2.210 |
Why?
|
| Strabismus | 5 | 2021 | 48 | 1.230 |
Why?
|
| Aphakia, Postcataract | 8 | 2024 | 21 | 1.170 |
Why?
|
| Ophthalmologic Surgical Procedures | 6 | 2019 | 87 | 1.090 |
Why?
|
| Ocular Hypertension | 2 | 2023 | 26 | 1.040 |
Why?
|
| Glaucoma | 3 | 2023 | 88 | 1.020 |
Why?
|
| Retinopathy of Prematurity | 3 | 2019 | 57 | 0.960 |
Why?
|
| Suture Techniques | 3 | 2015 | 196 | 0.830 |
Why?
|
| Pseudophakia | 6 | 2024 | 73 | 0.780 |
Why?
|
| Iris | 2 | 2015 | 65 | 0.780 |
Why?
|
| Abscess | 5 | 2019 | 138 | 0.760 |
Why?
|
| Postoperative Complications | 6 | 2019 | 3062 | 0.750 |
Why?
|
| Graves Ophthalmopathy | 1 | 2021 | 12 | 0.730 |
Why?
|
| Eye Infections, Bacterial | 3 | 2019 | 92 | 0.700 |
Why?
|
| Oculomotor Muscles | 4 | 2021 | 64 | 0.680 |
Why?
|
| Lasers, Semiconductor | 1 | 2019 | 9 | 0.650 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2019 | 12 | 0.640 |
Why?
|
| Lenses, Intraocular | 4 | 2020 | 396 | 0.640 |
Why?
|
| Ectopia Lentis | 2 | 2015 | 12 | 0.590 |
Why?
|
| Child, Preschool | 26 | 2024 | 13998 | 0.570 |
Why?
|
| Nystagmus, Pathologic | 1 | 2016 | 22 | 0.530 |
Why?
|
| Laser Therapy | 1 | 2019 | 248 | 0.530 |
Why?
|
| Follow-Up Studies | 12 | 2024 | 5132 | 0.530 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 3 | 2020 | 102 | 0.520 |
Why?
|
| Cellulitis | 2 | 2007 | 64 | 0.520 |
Why?
|
| Dermoid Cyst | 2 | 2006 | 34 | 0.510 |
Why?
|
| Orbital Diseases | 2 | 2007 | 92 | 0.500 |
Why?
|
| Infant | 20 | 2024 | 12466 | 0.460 |
Why?
|
| Anterior Eye Segment | 1 | 2014 | 30 | 0.450 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2014 | 50 | 0.450 |
Why?
|
| Sclera | 1 | 2014 | 58 | 0.450 |
Why?
|
| Retrospective Studies | 20 | 2024 | 16273 | 0.450 |
Why?
|
| Cornea | 1 | 2019 | 654 | 0.440 |
Why?
|
| Child | 25 | 2023 | 24356 | 0.420 |
Why?
|
| Hemangioma, Capillary | 1 | 2013 | 17 | 0.410 |
Why?
|
| Eyelid Neoplasms | 1 | 2013 | 43 | 0.400 |
Why?
|
| Propranolol | 1 | 2013 | 127 | 0.400 |
Why?
|
| Adolescent | 21 | 2023 | 19243 | 0.380 |
Why?
|
| Refractive Errors | 3 | 2022 | 85 | 0.370 |
Why?
|
| Posterior Capsule of the Lens | 1 | 2011 | 2 | 0.360 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2013 | 243 | 0.360 |
Why?
|
| Orbital Myositis | 1 | 2010 | 4 | 0.350 |
Why?
|
| Orbital Pseudotumor | 1 | 2010 | 11 | 0.350 |
Why?
|
| Dacryocystitis | 1 | 2010 | 20 | 0.350 |
Why?
|
| Photography | 2 | 2002 | 95 | 0.340 |
Why?
|
| Vision Disorders | 4 | 2022 | 211 | 0.340 |
Why?
|
| Humans | 46 | 2024 | 124143 | 0.340 |
Why?
|
| Male | 30 | 2024 | 60992 | 0.340 |
Why?
|
| Play and Playthings | 1 | 2009 | 17 | 0.320 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2009 | 19 | 0.320 |
Why?
|
| Treatment Outcome | 11 | 2020 | 12286 | 0.320 |
Why?
|
| Aphakia | 2 | 2022 | 8 | 0.320 |
Why?
|
| Eye Injuries | 1 | 2009 | 48 | 0.310 |
Why?
|
| Orbit | 1 | 2009 | 102 | 0.300 |
Why?
|
| Orbital Cellulitis | 1 | 2008 | 15 | 0.290 |
Why?
|
| Female | 28 | 2024 | 66274 | 0.290 |
Why?
|
| Eye Enucleation | 1 | 2008 | 54 | 0.290 |
Why?
|
| Anesthesia, Local | 1 | 2008 | 48 | 0.280 |
Why?
|
| Anesthesia, General | 1 | 2008 | 117 | 0.270 |
Why?
|
| Time Factors | 6 | 2019 | 6281 | 0.270 |
Why?
|
| Eyebrows | 1 | 2006 | 13 | 0.260 |
Why?
|
| Cytomegalovirus Infections | 2 | 2019 | 218 | 0.260 |
Why?
|
| Orbital Neoplasms | 1 | 2006 | 65 | 0.260 |
Why?
|
| Amblyopia | 2 | 2020 | 30 | 0.250 |
Why?
|
| Periostitis | 1 | 2005 | 2 | 0.250 |
Why?
|
| Endophthalmitis | 1 | 2004 | 77 | 0.220 |
Why?
|
| Xanthomatosis, Cerebrotendinous | 1 | 2023 | 4 | 0.210 |
Why?
|
| Endocarditis, Bacterial | 1 | 2004 | 132 | 0.210 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 555 | 0.210 |
Why?
|
| Glucocorticoids | 1 | 2005 | 380 | 0.200 |
Why?
|
| Exotropia | 1 | 2002 | 14 | 0.200 |
Why?
|
| Nail Diseases | 1 | 2022 | 15 | 0.200 |
Why?
|
| Blepharoplasty | 1 | 2002 | 22 | 0.200 |
Why?
|
| Refraction, Ocular | 1 | 2024 | 306 | 0.200 |
Why?
|
| Corneal Ulcer | 1 | 2022 | 56 | 0.190 |
Why?
|
| Mydriasis | 1 | 2021 | 7 | 0.190 |
Why?
|
| Hyperhidrosis | 1 | 2021 | 9 | 0.190 |
Why?
|
| Blepharoptosis | 1 | 2002 | 67 | 0.190 |
Why?
|
| Keratitis | 1 | 2022 | 116 | 0.190 |
Why?
|
| Pseudomonas Infections | 1 | 2022 | 115 | 0.180 |
Why?
|
| Eye Infections, Viral | 2 | 2019 | 28 | 0.180 |
Why?
|
| Intraoperative Complications | 3 | 2019 | 173 | 0.180 |
Why?
|
| Vision Screening | 1 | 2020 | 7 | 0.170 |
Why?
|
| Reflex | 1 | 2020 | 51 | 0.170 |
Why?
|
| Aconitate Hydratase | 1 | 2020 | 11 | 0.170 |
Why?
|
| Prospective Studies | 5 | 2023 | 6121 | 0.170 |
Why?
|
| Telepathology | 1 | 2000 | 3 | 0.170 |
Why?
|
| Ophthalmology | 3 | 2010 | 198 | 0.170 |
Why?
|
| Optic Atrophy | 1 | 2020 | 47 | 0.170 |
Why?
|
| Conjunctival Diseases | 1 | 2019 | 33 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2023 | 4780 | 0.150 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 270 | 0.140 |
Why?
|
| Visual Cortex | 1 | 2019 | 125 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2019 | 259 | 0.140 |
Why?
|
| Lacrimal Apparatus | 2 | 2010 | 122 | 0.140 |
Why?
|
| Artificial Lens Implant Migration | 1 | 2015 | 9 | 0.130 |
Why?
|
| Infant, Newborn | 7 | 2017 | 8189 | 0.120 |
Why?
|
| Lacrimal Apparatus Diseases | 2 | 2006 | 48 | 0.120 |
Why?
|
| Depth Perception | 1 | 2014 | 21 | 0.120 |
Why?
|
| Contact Lenses | 1 | 2014 | 45 | 0.110 |
Why?
|
| Texas | 3 | 2020 | 3578 | 0.110 |
Why?
|
| Incidence | 2 | 2019 | 3134 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 2089 | 0.100 |
Why?
|
| Gestational Age | 3 | 2019 | 1160 | 0.090 |
Why?
|
| Phacoemulsification | 1 | 2014 | 236 | 0.090 |
Why?
|
| Prosthesis Design | 1 | 2014 | 682 | 0.090 |
Why?
|
| Lasers, Solid-State | 1 | 2011 | 17 | 0.090 |
Why?
|
| Clothing | 1 | 2010 | 9 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2013 | 681 | 0.090 |
Why?
|
| Exophthalmos | 1 | 2010 | 37 | 0.090 |
Why?
|
| Hypertrophy | 1 | 2010 | 102 | 0.090 |
Why?
|
| Pediatrics | 2 | 2010 | 1157 | 0.080 |
Why?
|
| Young Adult | 4 | 2023 | 8990 | 0.080 |
Why?
|
| Patients | 1 | 2010 | 118 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3151 | 0.080 |
Why?
|
| Baseball | 1 | 2009 | 6 | 0.080 |
Why?
|
| Fixation, Ocular | 1 | 2009 | 16 | 0.080 |
Why?
|
| Patient Preference | 1 | 2010 | 116 | 0.080 |
Why?
|
| Trauma Severity Indices | 1 | 2009 | 88 | 0.080 |
Why?
|
| Athletic Injuries | 1 | 2009 | 58 | 0.080 |
Why?
|
| Wounds, Penetrating | 1 | 2009 | 140 | 0.080 |
Why?
|
| Ethmoid Sinusitis | 1 | 2008 | 3 | 0.080 |
Why?
|
| Registries | 3 | 2020 | 1420 | 0.070 |
Why?
|
| Anesthetics, Combined | 1 | 2008 | 7 | 0.070 |
Why?
|
| Foreign-Body Migration | 1 | 2008 | 72 | 0.070 |
Why?
|
| Postoperative Period | 1 | 2009 | 329 | 0.070 |
Why?
|
| Orbital Implants | 1 | 2008 | 18 | 0.070 |
Why?
|
| Methicillin Resistance | 1 | 2008 | 118 | 0.070 |
Why?
|
| Anesthetics, Inhalation | 1 | 2008 | 45 | 0.070 |
Why?
|
| Conscious Sedation | 1 | 2008 | 62 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2008 | 83 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 429 | 0.070 |
Why?
|
| Eye Diseases | 1 | 2008 | 116 | 0.070 |
Why?
|
| Biopsy | 1 | 2010 | 1237 | 0.070 |
Why?
|
| Drainage | 1 | 2008 | 257 | 0.070 |
Why?
|
| Pain Measurement | 1 | 2008 | 352 | 0.060 |
Why?
|
| Epithelial Cells | 1 | 2011 | 908 | 0.060 |
Why?
|
| Sinusitis | 1 | 2007 | 116 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2007 | 1223 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 1879 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2002 | 2041 | 0.060 |
Why?
|
| Prognosis | 2 | 2009 | 4609 | 0.060 |
Why?
|
| Eye Neoplasms | 1 | 2006 | 49 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2002 | 2141 | 0.060 |
Why?
|
| Esotropia | 1 | 2005 | 11 | 0.060 |
Why?
|
| Dermatitis, Perioral | 1 | 2004 | 2 | 0.060 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 332 | 0.060 |
Why?
|
| Pain, Postoperative | 1 | 2008 | 261 | 0.060 |
Why?
|
| Data Collection | 1 | 2006 | 382 | 0.060 |
Why?
|
| Adult | 6 | 2023 | 29339 | 0.060 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2005 | 50 | 0.060 |
Why?
|
| Eyelid Diseases | 1 | 2004 | 73 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 473 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2008 | 542 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2005 | 547 | 0.060 |
Why?
|
| Inpatients | 1 | 2008 | 493 | 0.050 |
Why?
|
| Cholestanol | 1 | 2023 | 3 | 0.050 |
Why?
|
| Bacteria | 1 | 2007 | 484 | 0.050 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2004 | 133 | 0.050 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 240 | 0.050 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 771 | 0.050 |
Why?
|
| Heart Valve Diseases | 1 | 2004 | 169 | 0.050 |
Why?
|
| Nails | 1 | 2022 | 17 | 0.050 |
Why?
|
| Ophthalmoscopy | 1 | 2002 | 28 | 0.050 |
Why?
|
| Antiperspirants | 1 | 2021 | 2 | 0.050 |
Why?
|
| Fundus Oculi | 1 | 2002 | 64 | 0.050 |
Why?
|
| Conjunctival Neoplasms | 1 | 2002 | 22 | 0.050 |
Why?
|
| Anisocoria | 1 | 2021 | 5 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2002 | 143 | 0.050 |
Why?
|
| Glycopyrrolate | 1 | 2021 | 9 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2004 | 197 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 242 | 0.040 |
Why?
|
| Operating Rooms | 1 | 2021 | 68 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 726 | 0.040 |
Why?
|
| Aortic Valve Stenosis | 1 | 2004 | 335 | 0.040 |
Why?
|
| Operative Time | 1 | 2021 | 169 | 0.040 |
Why?
|
| Vision Tests | 1 | 2019 | 38 | 0.040 |
Why?
|
| Syndrome | 1 | 2022 | 1118 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 579 | 0.040 |
Why?
|
| Rhabdomyosarcoma | 1 | 2002 | 191 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2000 | 231 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2002 | 748 | 0.040 |
Why?
|
| Nurses | 1 | 2000 | 64 | 0.040 |
Why?
|
| Medical Errors | 1 | 2021 | 155 | 0.040 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2002 | 314 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2006 | 779 | 0.040 |
Why?
|
| Physical Examination | 1 | 2000 | 159 | 0.040 |
Why?
|
| Middle Aged | 2 | 2009 | 26587 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2017 | 1179 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2002 | 1629 | 0.040 |
Why?
|
| Hospitalization | 1 | 2005 | 1769 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 6464 | 0.030 |
Why?
|
| Prevalence | 1 | 2023 | 2445 | 0.030 |
Why?
|
| United Kingdom | 1 | 2016 | 189 | 0.030 |
Why?
|
| Telemedicine | 1 | 2002 | 429 | 0.030 |
Why?
|
| North America | 1 | 2016 | 239 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2007 | 2420 | 0.030 |
Why?
|
| Birth Weight | 1 | 2017 | 346 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2020 | 875 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 3549 | 0.030 |
Why?
|
| Exome | 1 | 2020 | 1035 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2002 | 2863 | 0.030 |
Why?
|
| Disease Progression | 1 | 2000 | 2046 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1318 | 0.030 |
Why?
|
| Aged | 2 | 2008 | 19532 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1421 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 4249 | 0.020 |
Why?
|
| Child, Hospitalized | 1 | 2008 | 71 | 0.020 |
Why?
|
| Laminectomy | 1 | 2005 | 27 | 0.020 |
Why?
|
| Dura Mater | 1 | 2005 | 25 | 0.020 |
Why?
|
| Risk Factors | 1 | 2019 | 10244 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 2005 | 90 | 0.010 |
Why?
|
| Parents | 1 | 2010 | 1012 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 1264 | 0.010 |
Why?
|
| Myogenin | 1 | 2002 | 10 | 0.010 |
Why?
|
| Desmin | 1 | 2002 | 21 | 0.010 |
Why?
|
| Acute Disease | 1 | 2005 | 1107 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 258 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 3683 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 1135 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2008 | 3414 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2006 | 1208 | 0.010 |
Why?
|